Trial Profile
Phase I trial of an antidementia therapeutic for Alzheimer's disease.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 10 Feb 2012
Price :
$35
*
At a glance
- Drugs Antidementias
- Indications Alzheimer's disease
- Focus Adverse reactions; Therapeutic Use
- 10 Feb 2012 New trial record